Renal Business Today

Clinical & Pharma

Kidney disease patients rely on numerous pharmaceuticals—including erythropoiesis-stimulating agents (ESAs),iron, Vitamin D, phosphate binders and calcium—to ensure proper care. In addition, new clinical research is released on a regular basis by nephrologists and other doctors to advance the field of nephrology.

Norovirus No. 1 Cause of Outbreaks in U.S. Hospitals

WASHINGTON―Norovirus, a pathogen that often causes food poisoning and gastroenteritis, was responsible for 18.2 percent of all infection outbreaks and 65 percent of ward closures in U.S. hospitals during a two-year period, according to a new study published in the February ...More
2 days ago
Posted in News, Clinical & Pharma
New Study Reconsiders Blood Pressure Targets for Kidney Disease Patients

NEW YORK— Blood pressure targets for those with kidney disease may have been more stringent than necessary, according to a new study in the January 9 issue of the Archives of Internal Medicine. ...More
3 weeks ago
Posted in News, Clinical & Pharma
FDA Updates Vytorin Label After CKD Study

WHITEHOUSE STATION, N.J.—The U.S. Food and Drug Administration (FDA) has approved an updated label for Merck's cholesterol drug Vytorin following results from the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease. ...More
3 weeks ago
Posted in News, Clinical & Pharma
Gastrointestinal Bleeding a Big Risk for Kidney-Failure Patients

WASHINGTON, DC—Bleeding in the upper gastrointestinal (GI) tract causes serious health problems—and even early deaths—for many patients with kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). ...More
3 weeks ago
Posted in News, Clinical & Pharma
Blood Protein Predicts Kidney Disease Risk in Diabetics

WASHINGTON— Levels of certain blood proteins indicate which diabetes patients will likely develop life-threatening kidney problems in the future, according to two studies published online Jan. 19 in the Journal of the American Society Nephrology (JASN). ...More
4 weeks ago
Posted in News, Clinical & Pharma
Researchers Creating New Ways to Fight Catheter Infections

COLLEGE PARK, Md.— Researchers at the University of Maryland's A. James Clark School of Engineering, backed by funding from the Robert W. Deutsch Foundation, are developing tools to combat catheter-based and other infections without provoking bacterial resistance to ...More
4 weeks ago
Posted in News, Clinical & Pharma
Liver Transplant Policy Change Increases Kidney Failure Risk

ANN ARBOR, Mich.— The risk for kidney failure among liver transplant recipients is higher following the implementation of Model of End Stage Liver Disease (MELD), a policy change in 2002 that altered how liver transplant allocation is decided, according to University of ...More
4 weeks ago
Posted in News, Clinical & Pharma
U.S. Obesity Prevalence Still High

CHICAGO—There has not been significant change in the prevalence of obesity in the United States with data from 2009-2010 indicating that about one in three adults and one in six children and teens are obese; however, there have been increases in certain demographics, ...More
4 weeks ago
Posted in News, Clinical & Pharma
Seniors Lack Access to Kidney Transplants

BALTIMORE—Thousands more American senior citizens with kidney disease are good candidates for transplants and could get them if physicians would get past outdated medical biases and put them on transplant waiting lists, according to a study published in the January 2012 ...More
4 weeks ago
Posted in News, Clinical & Pharma
DOPPS: EPO Doses Drop 15% in One Year

WASHINGTON—In the wake of a number of regulatory and payment changes in ESRD care, nephrologists are changing their behavior in anemia management. This is evident in the drop in prescribed epoetin doses and hemoglobin levels in dialysis patients, according to the latest ...More
5 weeks ago
Posted in News, Clinical & Pharma, Practice Management

featured links

HOT TOPICS